Chester County News and Community Website
BERWYN, PA — Virpax Pharmaceuticals, Inc. (Nasdaq: VRPX) has commended Nanomerics for the successful completion of a human study utilizing its proprietary Molecular Envelope Technology (MET). The Phase I SUNLIGHT trial …
Virpax Pharmaceuticals Applauds Successful Trial of Molecular Envelope Technology Read More
WASHINGTON, D.C. — Provisional data from the Centers for Disease Control and Prevention (CDC) reveals a nearly 24% decrease in drug overdose deaths in the United States for the 12-month …
Over 27,000 Lives Saved: CDC Reports Unprecedented Drop in U.S. Overdose Deaths—The Fight Isn’t Over Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration (FDA) has announced several significant developments this week, spanning advancements in allergy treatment, diabetes management, and Parkinson’s disease therapy, as well …
FDA Takes Action on Allergies, Diabetes, Parkinson’s, and Deadly Food Safety Scare—What You Need to Know Read More
WASHINGTON, D.C. — The Centers for Disease Control and Prevention (CDC) has issued a food safety alert regarding a multistate outbreak of Listeria infections linked to supplement shakes distributed in …
Deadly Listeria Outbreak Targets Vulnerable Seniors—Are Long-Term Care Facilities Safe Enough? Read More
WASHINGTON, D.C. — The Centers for Disease Control and Prevention (CDC) has confirmed that it is working closely with Texas health officials following a measles outbreak in West Texas that …
Protect Your Family—CDC Sounds Alarm After Measles Outbreak Claims Child’s Life in Texas Read More
CONSHOHOCKEN, PA — The GBS | CIDP Foundation International has unveiled survey data that paints a sobering picture of the physical, social, and financial challenges faced by individuals with Guillain-Barré Syndrome …
New Survey Sheds Light on Guillain-Barré Syndrome Challenges Read More
PHILADELPHIA, PA — A groundbreaking discovery from Dr. Filippo Veglia’s lab at The Wistar Institute has revealed how aggressive brain tumors reprogram immune cells, turning them from cancer-fighters into enablers …
Wistar Researchers Uncover Key Mechanism Behind Brain Tumor Immune Suppression Read More
MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN) announced a significant milestone with the U.S. Food and Drug Administration (FDA), gaining alignment to advance its Phase 2/3 pivotal confirmatory trial of OCU410ST, …
FDA Greenlights Ocugen’s Breakthrough Gene Therapy Trial, Offering New Hope for Stargardt Disease Patients Read More
HARRISBURG, PA — State leaders, including Department of Drug and Alcohol Programs (DDAP) Secretary Dr. Latika Davis-Jones, gathered alongside representatives from the Pennsylvania Lottery, the Pennsylvania Gaming Control Board (PGCB), …
Pennsylvania Rallies to Tackle Gambling Addiction: Resources, Stories, and Hope for Recovery Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration (FDA) has announced its recent approval of Ctexli (chenodiol), marking the first-ever treatment for cerebrotendinous xanthomatosis (CTX), a rare and debilitating …
FDA Breakthrough: First-Ever Treatment Approved for Rare and Devastating CTX Disorder! Read More